“Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design”. 2024. Dhaka University Journal of Pharmaceutical Sciences 23 (2): 135-43. https://doi.org/10.3329/dujps.v23i2.78571.